FDA Inspection
Pfizer Manufacturing Belgium NVPfizer Manufacturing Belgium NV – FDA Inspection, Jun 8, 2023
Record Details
This FDA Inspection record concerns Pfizer Manufacturing Belgium NV, with an inspection on June 8, 2023, issued by the Center for Devices and Radiological Health, covering devices.
View Company Profile
ID · e92313bc-270f-4150-bfb5-9e3b7ba4fd0a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208904
- FDA center
- Medical Devices & Rad Health
- Project area
- Compliance: Devices
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 820.100(b)Documentation
- 21 CFR 820.100(b)Documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer Manufacturing Belgium NV
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2024 | Not classified | Office of Inspections and Investigations | |
| May 17, 2024 | Not classified | Office of Inspections and Investigations | |
| May 16, 2023 | Not classified | Office of Inspections and Investigations | |
| June 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Manufacturing Belgium NV
- FDA Inspection 1240714 - 2024-06-28
- FDA Inspection 1239799 - 2024-05-17
- FDA Inspection 1214848 - 2023-05-16
- FDA Inspection 1203291 - 2022-06-22
- FDA Inspection 1036703 - 2017-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.